Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Leucrex vs boric acid in recurrent vulvovaginal candidiasis
IRCT2012102911302N1Phase 4Completed
- Sponsor
- Herbal medicine of shahed unversity
- Start
- Mar 2010
- Modality
- Small Molecules, Peptides, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of leuprolide and boric acid in vulvovaginal candidiasis (VVC) (2 arms), sponsored by Herbal medicine of shahed unversity. Started Mar 2010; status: completed.
02
Drugs
leuprolideboric acid
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on IRCT2012102911302N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2012102911302N1.